In the News
PPD, Evidera join MIT ‘think and do’ tank as a strategic partner
PPD becomes the first contract research organization to join the MIT Center for Biomedical Innovation’s New Drug Development Paradigms (NEWDIGS).
Improvements to Study Startup Underway
Gaurav Bhatnagar comments on how technology and data-driven approaches will be key to “bending the cost and time curve” of drug development.
Patient-Centered Apps
Acurian’s Scott Connor notes that the most important aspect when designing any app is to create something that has a singular purpose.
How PPD plans to enroll patients for this competitive area of study
Acurian and Synexus have launched a comprehensive solution for enrolling patients in clinical studies for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Acurian, Synexus tap database of 100m for NASH patient enrollment solution
The companies will combine efforts to enable trial sponsors to find, qualify and enroll NAFLD and NASH patients more effectively and efficiently.
PPD to run ‘patient concierge’ trial service
Nik Morton and Roger Smith discuss how this new program serves as a single point of contact to help proactively guide patients through trials.
Catch (& Keep) a Rising Star: Clinical Research Talent Trends
In this article, Tim Neathery notes that more people are becoming aware of the positive aspects of building a career in the clinical research space.
Best Practices for Testing Foreign Particulate Matter in Inhaled Products
John Bak talks about developing appropriate tests for addressing foreign particles in orally inhaled and nasal drug products.
PPD expands analytical lab to meet ‘growing’ demand for biologics testing
Jon Denissen explains that the expansion is part of the company’s ongoing efforts to meet the ever-increasing needs of its biopharmaceutical clients for GMP testing of large molecule products.